2014 - Dialogue on Disparities
-
Dr. Dana-Lynn Koomoa-Lange, a CRCHD K01 grantee, is exploring signaling pathways in the progression of neuroblastoma, a nervous system cancer, in an effort to develop new drugs to thwart the disease.
-
Dr. Joseph Kofi Agyin, a CRCHD R21 Grantee, is studying the design and synthesis of bone-targeted proteasome inhibitors for treating multiple myeloma.